What's hot
View all perspectives
What's Hot
RheumNow Rheumatology Roundup: Drs. Kavanaugh and Cush
Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021.
Watch video →
TNF Inhibitor Panel Discussion: ACR21 Annual Meeting
RheumNow TNFi faculty convened to discuss several TNFi-related abstracts presented at ACR 21. Panelists: Drs. Aurelie Najm, Janet Pope, David Liew, Eric Dein and Swetha Alexander.
Watch video →
Spondyloarthritis Panel Discussion: ACR21 Meeting
Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood. Abstracts discussed include #0562, #1919, #0907, #0364 and #0919
Watch video →
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Dr. Kay discusses abstract 1940 and abstract 980 presented at the ACR21 annual meeting.
Watch video →
Diagnosing (Bad) VEXAS: The Experts Speak Drs. Beck and Ferrada
Dr. Cush discusses Dr. Marcela Ferrada and Dr. David Beck to discuss VEXAS syndrome and abstract 1426, which was presented at the ACR21 annual meeting.
Watch video →
Pediatric Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses abstracts #1424 presented at the ACR21 annual meeting.
Watch video →
Urine Proteome Advances: What Do They Mean? Dr. Michelle Petri
Dr. Petri reviews abstracts #1422 and #1936, presented at the ACR21 annual meeting.
Watch video →
ACR21 Day 3 Recap: Polypharmacy, New Lupus Drugs, VEXAS, Safety Data
Blurb: Drs. Jack Cush and the RheumNow Faculty Drs. Akhil Sood, Antoni Chan, Olga Petryna and Eric Dein, discuss highlights from Day 3 (Monday) at the ACR21 annual meeting. Abstracts include #1367, #1044, #1444, #1083 and more.
Watch video →
Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles
Dr. Giles discusses abstracts #0831and #0958 presented at the ACR21 annual meeting.
Watch video →
Predictors of TNF Response with Drs. Pope, Dein and Liew
Drs. Janet Pope, David Liew and Eric Dein discuss TNF data presented at the ACR21 annual meeting, including abstracts #1251, #1442, #1448.
Watch video →
Caring for the Older Patient with Rheumatic Disease: Drs. Makris, Yung and Dao
Drs. Kathryn Dao, Una Makris and Raymond Yung discuss the field of geriatric rheumatology and caring for the older patient with rheumatic disease.
Watch video →
Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares
Drs. Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna and Rachel Tate review autoinflammatory data presented at the ACR21 annual meeting, including abstracts #1100, #1062, #1426, #0252, #0195, and #1083.
Watch video →
FDA Session Review: Dr. Arthur Kavanaugh
Dr. Kavanaugh discussed the FDA session presented at the ACR21 annual meeting, including safety data and new approvals and indications in several rheumatic diseases, including lupus, ANCA-associated vasculitis, lupus nephritis and more.
Watch video →
The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer
Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the ACR21 annual meeting.
Watch video →
Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush
Dr. Cush reviews poster #1100 presented at the ACR21 annual meeting.
Watch video →
Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri
Dr. Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the ACR21 annual meeting.
Watch video →
ACR21 Day 2 Recap: CV Risk, Tapering in SpA, Microbiome in PsA, Vit D
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 (Sunday) at the ACR21 Virtual meeting.
Watch video →
Richard Conway RichardPAConway
4 years ago
@zach_wallace_md on RTX vs CYC remission induction in AAV. Multivariable and propensity score matching. No difference in ESRD or mortality. Real world confirmation of RAVE. Abstr#954 #ACR21 @RheumNow https://t.co/oSauqV8JnD
Olga Petryna DrPetryna
4 years ago
Abst0944 #ACR21 #ACRBest @RheumNow microbiom evaluation of MZ twins discordant for PSO reveals Ruminococcus bromii species significantly reduced & two pathways related to tetrahydrofolate biosynthesis upregulated in PSO twins compared to their unaffected siblings (p< 0.05) https://t.co/67ao0l23sI
Eric Dein ericdeinmd
4 years ago
#ACR21 Clinical Pearl: Beware of low cholesterol!
Systemic inflammation can lower cholesterol levels! High inflammation and low cholesterol may INCREASE, not decrease risk of CVD!
This is the "lipid paradox"
@Rheumnow https://t.co/dK7hD8zkVP
Pedro Castillo _Castillo_Pedro
4 years ago
Soluble urinary ALCAM previously shown as potential biomarker for LN. Further study showing urinary ALCAM trended with changes in renal-SLEDAI and UPCr.
#ACR21 Abst#3053 @RheumNow https://t.co/IqVJej7yda
Olga Petryna DrPetryna
4 years ago
Abst 0947 #ACR21 @RheumNow KikGR x TNFDARE/+ mice study assessed contribution of gut-derived T cells to increased joint inflammation through production of pro-inflammatory cytokines like IL-17 and TNF. Photolabeled gut-trafficked T cells are observed in the Achilles enthesis
Bella Mehta bella_mehta
4 years ago
Important to discuss men with #lupus
Nationwide claims study showed increased occurrence of multimorbidity in men with SLE compared to women with SLE #ACR21 @RheumNow @AliDuarteMD Abst#0579 #ACRBest https://t.co/ljflGU84Ro
Dr. Rachel Tate uptoTate
4 years ago
No evidence to show increased risk of incident hypertension w/ TNFi use, after accounting for baseline & time-dependent confounding factors, in prospective AS cohort. Abs 0910 #ACR21 #RheumNow @RheumNow https://t.co/1SpQ51ftlK
Dr. Rachel Tate uptoTate
4 years ago
Ear dyspigmentation, scalp dyspigmentation and scarring alopecia found more frequently in Black DLE pts. Findings may help assist in dx and tx plans. Abs 0598 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/a1pxWHJ7b5
David Liew drdavidliew
4 years ago
Does AAV induction choice (CYC v RTX) affect long-term outcomes (that might be missed in clinical trials)?
Boston data done two ways: multivar analysis & trial emulation using PS
CYC and RTX-based induction both perform equally well over many years👍
#ACR21 ABST0954 @RheumNow https://t.co/8BZRgKiQNB
Richard Conway RichardPAConway
4 years ago
Dr Strand presents HRQoL measures for avacopan from ADVOCATE trial. Better HRQoL outcomes with avacopan. Great to have PRO data. Abstr#0955 #ACR21 @RheumNow https://t.co/9qBAHETX7s
Dr. Rachel Tate uptoTate
4 years ago
French, real-world axSpA cohort analysis shows SEC and TNFi retention rates similar. What do you see in your practice? Abs 0911 #ACR21 #RheumNow @RheumNow https://t.co/vu3zUwfktl https://t.co/v6DLjWJMn4
The RheumNow faculty have been glued to their monitors all day, watching video, and running down abstract presentations to find the best – several of these stood out as #ACRBests. Here is a listing of “Best” they saw on Day 1.
Patients with axial spondyloarthritis (axSpA) often have increased absence from work as well as reduced productivity at work, which can have profound impacts for not only the affected individual and their families, but also lead to wider economic and social burden.
The ACR meeting is the premier educational event in rheumatology every year; it’s big for clinicians, academics, North American and international rheumatologists and those who will be presenting their research for the first time.
Your objectives in attending the annual meeting are:
Podcasts
Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie00:20:18 -
Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao
00:20:26 -
The Expert Gout Panel with Drs. Neogi, Saag, Pillinger, Cush and O'Dell
00:35:26
Poster Hall